Japan's interest in longevity medicine is deeply rooted in one of the world's longest-lived populations, yet access to advanced anti-ageing protocols through the PMDA-regulated healthcare system remains limited and costly. Comprehensive programmes combining NAD+ optimisation, peptide therapy, and biomarker-guided regenerative protocols are available at only a handful of premium Japanese clinics at substantially higher prices. Our Chiang Mai clinic, approximately six hours from Tokyo or Osaka, offers complete anti-ageing medicine with Japanese-speaking support.
Anti-ageing therapy at Longevity Thailand targets the biological mechanisms of ageing at the cellular level. Protocols may include NAD+ optimisation, peptide therapy, and regenerative infusions, all tailored to your individual biomarker profile. For a comprehensive understanding of the science and treatment process, visit our full Anti-Ageing Treatment page.
Japanese patients choose Longevity Thailand for anti-ageing treatment because of the comprehensive biomarker-driven approach that goes beyond what is typically available at home. Personalised protocols are designed around individual blood panel results rather than standardised packages. The cost of a full five to ten day programme represents significant savings compared to equivalent treatments domestically, and Japanese-speaking support ensures clear communication about complex longevity science. Structured remote follow-up with repeat biomarker testing through your local laboratory maintains continuity of care.
Some elements are available at private clinics in Japan, but at significantly higher costs. The advanced regenerative protocols we offer, including specific NAD+ and peptide therapies, are not widely available domestically.
A typical anti-ageing programme takes five to ten days, depending on the protocols selected.
Yes. Pre-arrival blood tests can be completed at any hospital or clinic in Japan. We provide the test panel in advance.
Treatment in Thailand is typically 55 to 70 percent more affordable than comparable programmes at private clinics in Tokyo or Osaka.
Yes. Our team includes Japanese-speaking coordinators to ensure seamless communication.
Structured video consultations are scheduled at regular intervals. Repeat biomarker testing can be done at any Japanese laboratory.
Yes. Japan's PMDA oversees regenerative and IV-based therapies. Many advanced NAD+ and peptide infusion protocols require approval under PMDA's therapeutic product framework, limiting clinical availability at domestic clinics.
No. Anti-ageing and longevity therapies are classified as elective and are not covered by NHI. Patients pay out of pocket at private clinics in Japan, where costs are substantially higher than comparable programmes in Thailand.
Direct or one-stop flights operate from Tokyo Narita (NRT) and Osaka Kansai (KIX) to Chiang Mai, with a total travel time of approximately 6 hours. Our Japanese-speaking coordinator can assist with flight recommendations and airport transfers.